Literature DB >> 21606259

Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.

Joan C Vilanova1, Carles Barceló-Vidal, Josep Comet, Maria Boada, Joaquim Barceló, Joana Ferrer, Joan Albanell.   

Abstract

OBJECTIVE: The purpose of the study was to assess the predictive value for prostate cancer of MRI using morphologic (T2-weighted imaging [T2WI]) and functional (MR spectroscopy [MRS], diffusion-weighted imaging [DWI], and dynamic contrast-enhanced [DCE] MRI) sequences and the free-to-total prostate-specific antigen (PSA) ratio, alone and combined.
MATERIALS AND METHODS: This retrospective study included 70 patients (PSA level, > 4 ng/mL; free-to-total PSA ratio, < 20%) who underwent endorectal 1.5-T MRI before biopsy. We graded the likelihood of cancer on a 5-point scale. Imaging data were compared with histologic results on biopsy or prostatectomy. Accuracies were estimated from the area under receiver operating characteristic using the hemiprostate as the unit of analysis. A p value less than 0.05 denoted statistical significance.
RESULTS: The model combining all variables was more accurate than each variable alone (95.2% vs 73.5% for T2WI, 76.0% for MRS, 81.8% for DWI, 75.6% for DCE-MRI, and 78.8% for free-to-total PSA ratio). The complete model had accuracy similar to that of combining two imaging variables with free-to-total PSA ratio, especially free-to-total PSA ratio, T2WI, and DWI (94.0%); and free-to-total PSA ratio, DWI, and MRS (93.8%); with negative predictive values of 91.0% and 89.5%, respectively. The best models combining two imaging variables (MRS and DWI, 85.8%; T2WI and DWI, 84.8%) had accuracy that was similar to that of the combination of all imaging variables (87.3%) and higher than that of the best individual imaging variable (DWI, 81.8%), but lower than that of the complete model.
CONCLUSION: The combination of at least one functional technique with free-to-total PSA ratio is more accurate than combining only imaging variables in cancer detection. The use of more than two imaging variables does not increase the detection rate. Functional MRI has the potential to help avoid a large number of negative biopsies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606259     DOI: 10.2214/AJR.10.5700

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Performance of T2 Maps in the Detection of Prostate Cancer.

Authors:  Aritrick Chatterjee; Ajit Devaraj; Melvy Mathew; Teodora Szasz; Tatjana Antic; Gregory S Karczmar; Aytekin Oto
Journal:  Acad Radiol       Date:  2018-05-03       Impact factor: 3.173

2.  Computed diffusion-weighted imaging of the prostate at 3 T: impact on image quality and tumour detection.

Authors:  Andrew B Rosenkrantz; Hersh Chandarana; Nicole Hindman; Fang-Ming Deng; James S Babb; Samir S Taneja; Christian Geppert
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

Review 3.  Current trends and new frontiers in focal therapy for localized prostate cancer.

Authors:  Melissa H Mendez; Daniel Y Joh; Rajan Gupta; Thomas J Polascik
Journal:  Curr Urol Rep       Date:  2015-06       Impact factor: 3.092

4.  Prostate multimodality image registration based on B-splines and quadrature local energy.

Authors:  Jhimli Mitra; Robert Martí; Arnau Oliver; Xavier Lladó; Soumya Ghose; Joan C Vilanova; Fabrice Meriaudeau
Journal:  Int J Comput Assist Radiol Surg       Date:  2011-06-26       Impact factor: 2.924

Review 5.  The emerging role of diffusion-weighted MRI in prostate cancer management.

Authors:  Edward M Lawrence; Vincent J Gnanapragasam; Andrew N Priest; Evis Sala
Journal:  Nat Rev Urol       Date:  2012-01-17       Impact factor: 14.432

6.  Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Wei Wei; Valen Johnson; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

7.  Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Brian Paul Hobbs; Wei Wei; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2015-04       Impact factor: 3.959

8.  Novel application of three-dimensional shear wave elastography in the detection of clinically significant prostate cancer.

Authors:  Sunao Shoji; Akio Hashimoto; Tomoya Nakamura; Shinichiro Hiraiwa; Haruhiro Sato; Yoshinobu Sato; Takuma Tajiri; Akira Miyajima
Journal:  Biomed Rep       Date:  2018-02-07

9.  Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.

Authors:  Daniel N Costa; B Nicolas Bloch; David F Yao; Martin G Sanda; Long Ngo; Elizabeth M Genega; Ivan Pedrosa; William C DeWolf; Neil M Rofsky
Journal:  Magn Reson Imaging       Date:  2013-04-18       Impact factor: 2.546

Review 10.  Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.

Authors:  Sunao Shoji; Shinichiro Hiraiwa; Izumi Hanada; Hakushi Kim; Masahiro Nitta; Masanori Hasegawa; Yoshiaki Kawamura; Kazunobu Hashida; Takuma Tajiri; Akira Miyajima
Journal:  Int J Clin Oncol       Date:  2020-02-10       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.